Cat.#: ACPP-1340
| Despition | PDE7A Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1298 | Syndecan-1 Blocking Peptide (AC1298) | 250 µg | inquiry |
| ACPP-1568 | Human NME4 Protein (AC1568) | 5 µg | inquiry |
| ACPP-1315 | GTP cyclohydrolase 1 Blocking Peptide (AC1315) | 250 µg | inquiry |
| ACPP-1497 | Human AMIGO2 Protein (AC1497) | 2 µg | inquiry |
| ACPP-1195 | CaMKII gamma Blocking Peptide (AC1195) | 250 µg | inquiry |
| ACPP-1039 | Recombinant Human FGFR4 Protein (6×His Tag) (AC1039) | 50 µg | inquiry |
| ACPP-1477 | Mouse I TAC Protein (AC1477) | 5 µg | inquiry |
| ACPP-1656 | Human MAPT Protein (AC1656) | 2 µg | inquiry |
| ACPP-1360 | Human GAD65 Protein (AC1360) | 1 mg | inquiry |
| ACPP-1433 | Human Interleukin 6 (Active) Protein (AC1433) | 100 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.